CBLL
CERIBELL (CBLL)
NASDAQ
$18.40+$0.005 (+0.03%)
Price as of Jun 23, 2026 5:37 PM EDT
  • $689.8M
    Market Cap
  • -1.68%
    1-Year Change
  • Medical Devices
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
67.3M
+2.89%
65.4M
N/A
Cost of Revenue
10.1M
+16.49%
8.7M
N/A
Gross Profit
78.3M
+37.93%
56.8M
N/A
Sales and Marketing Expense
73.1M
+48.98%
49.1M
N/A
Research and Development Expense
-19.1M
+41.15%
-13.6M
N/A
Depreciation and Amortization Expense
1.3M
+17.53%
1.1M
N/A
Total Operating Expenses
136.7M
+41.69%
96.5M
N/A
Operating Profit
-58.4M
+47.07%
-39.7M
N/A
Interest Income
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
Total Nonoperating Income and Expense
6.9M
+150.91%
2.7M
N/A
Income before Taxes
-53.4M
+32.03%
-40.5M
N/A
Income Taxes
0
-100.00%
11,000
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
-53.4M
+32.03%
-40.5M
N/A
Net Income from Continuing Operations Applicable to Common
-53.4M
+32.03%
-40.5M
N/A
Basic EPS and Net Income
-1.46
-56.93%
-3.39
N/A
Diluted EPS and Net Income
-1.46
-56.93%
-3.39
N/A
Basic Weighted Average Shares
36.5M
+205.79%
11.9M
N/A
Diluted Weighted Average Shares
36.5M
+205.79%
11.9M
N/A
Balance Sheet
Cash and Cash Equivalents
40.5M
-79.18%
194.4M
N/A
Short-Term Investments
118.8M
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
159.3M
-18.06%
194.4M
N/A
Total Current Assets
186.7M
-14.06%
217.3M
N/A
Accumulated Depreciation
2.7M
+59.93%
1.7M
N/A
Property and Plant and Equipment and Net
2.0M
-12.24%
2.3M
N/A
Total Long-Term Assets
2.9M
+33.09%
2.2M
N/A
Total Assets
195.8M
-13.14%
225.4M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
11.8M
N/A
Total Current Liabilities
19.2M
+47.74%
13.0M
N/A
Total Long-Term Debt
19.8M
+1.29%
19.6M
N/A
Total Long-Term Liabilities
21.3M
+0.09%
21.3M
N/A
Total Liabilities
40.5M
+18.16%
34.2M
N/A
Retained Earnings
-220.4M
+31.99%
-166.9M
N/A
Total Stockholders Equity
155.3M
-18.74%
191.2M
N/A
Total Shares Outstanding
37.5M
+4.56%
35.9M
N/A
Cash Flow
Cash from Operating Activities
-40.8M
+16.45%
-35.0M
N/A
Capital Expenditures
767,000
-42.76%
1.3M
N/A
Cash from Investing Activities
-118.1M
+7,292.80%
-1.6M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
5.1M
-97.43%
196.5M
N/A
Financials Ratio
Gross Margin
84.96%
N/A
N/A
N/A
Operating Margin
-86.73%
N/A
N/A
N/A
Return on Assets
-25.36%
N/A
N/A
N/A
Return on Equity
-30.83%
N/A
N/A
N/A
Revenue Growth
2.89%
N/A
N/A
N/A
Current Ratio
9.73
N/A
N/A
N/A
Cash Ratio
2.11
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow